Login / Signup

Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis.

Shintaro AkiyamaShadi HamdehDejan MicicAtsushi Sakuraba
Published in: Annals of the rheumatic diseases (2020)
Our meta-analysis demonstrated that patients with autoimmune diseases had an increased risk of COVID-19, primarily attributed to glucocorticoid use. b/tsDMARDs monotherapy was associated with a lower risk of severe COVID-19 suggesting its safety in the COVID-19 pandemic.
Keyphrases
  • coronavirus disease
  • sars cov
  • systematic review
  • respiratory syndrome coronavirus
  • risk factors
  • early onset
  • clinical trial
  • randomized controlled trial
  • open label
  • combination therapy
  • meta analyses
  • drug induced